HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies Targeting Long Non-coding RNAs
Lausanne, Switzerland, 20 May 2021 -- HAYA Therapeutics, SA, a company developing precision medicines that...
Search for Articles
May 20, 2021
Mar 23, 2021
Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.
PHILADELPHIA and NEW YORK, March 23, 2021 /PRNewswire/ -- Renovacor, Inc. ("Renovacor" or the "Company"), an...
Dec 7, 2020
Basking Biosciences, Inc. Completes $5.4M Seed Financing
December 07, 2020 08:30 AM Eastern Standard Time COLUMBUS, Ohio--(BUSINESS WIRE)--Basking Biosciences, Inc. (Basking), a...
Nov 30, 2020
Vectorious’ in-heart microcomputer is granted FDA breakthrough designation
November 30, 2020. Vectorious Medical Technologies today announced that the FDA has granted breakthrough device...
Oct 20, 2020
FineHeart Achieves Milestone for its Miniaturized Heart Pump Technology with Successful Completion of 30-Day Preclinical Study
Bordeaux, France - October 20, 2020. – FineHeart, SA, a preclinical-stage medical device company developing...
Jul 22, 2020
FineHeart: An LVAD Works in Synchrony with the Heart
Founded by electrophysiologists, FineHeart has developed an LVAD that is like no other. It resides...